Long-term Efficacy of Filgotinib Monotherapy and Combination Therapy: Interim Results from a Post Hoc Analysis of the FINCH 4 Study

被引：0
|
作者：
Buch, Maya H. [1 ,2 ]
Verschueren, Patrick [3 ,4 ]
Caporali, Roberto [5 ,6 ]
Huizinga, Thomas [7 ]
Omoruyi, Edmund V. Ekoka [8 ]
de Vries, Dick [9 ]
Ritsema, Jeffrey [10 ]
De Leonardis, Francesco [11 ]
Aletaha, Daniel [12 ]
机构：
[1] Univ Manchester, Div Musculoskeletal & Dermatol Sci, Manchester, Lancs, England
[2] NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England
[3] Univ Hosp Leuven, Dept Rheumatol, Leuven, Belgium
[4] Katholieke Univ Leuven, Leuven, Belgium
[5] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[6] ASST Gaetano Pini CTO, Dept Rheumatol & Med Sci, Milan, Italy
[7] Leiden Univ, Dept Rheumatol, Leiden, Netherlands
[8] Galapagos NV, Biostat, Mechelen, Belgium
[9] Galapagos BV, Clin Dev, Leiden, Netherlands
[10] Galapagos BV, Med Affairs, Leiden, Netherlands
[11] Galapagos GmbH, Med Affairs, Basel, Switzerland
[12] Med Univ Vienna, Div Rheumatol, Dept Med 3, Vienna, Austria
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2252
引用
收藏
页码：4531 / 4534
页数：4
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF FILGOTINIB IN PATIENTS AGED ≥75 YEARS: A POST HOC SUBGROUP ANALYSIS OF THE FINCH 4 LONG-TERM EXTENSION (LTE) STUDY
    Aletaha, D.
    Westhovens, R.
    Combe, B.
    Gottenberg, J. E.
    Buch, M. H.
    Caporali, R.
    Gomez-Puerta, J. A.
    Van Hoek, P.
    Rajendran, V.
    Stiers, P. J.
    Hendrikx, T.
    Burmester, G. R.
    Tanaka, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 612 - 613
  • [2] Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study
    Buch, Maya H.
    Aletaha, Daniel
    Combe, Bernard G.
    Tanaka, Yoshiya
    Caporali, Roberto
    Schulze-Koops, Hendrik
    Takeuchi, Tsutomu
    Gottenberg, Jacques-Eric
    Blanco, Ricardo
    Verschueren, Patrick
    Zubrzycka-Sienkiewicz, Anna
    De Leonardis, Francesco
    Omoruyi, Edmund V. Ekoka
    Rajendran, Vijay
    Emery, Paul
    RMD OPEN, 2024, 10 (04):
  • [3] SAFETY OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: ANALYSIS OF LYMPHOCYTES IN THE LONG-TERM EXTENSION FINCH 4 STUDY
    Gottenberg, J. E.
    Burmester, G. R.
    Van Beneden, K.
    Watson, C.
    Seghers, I.
    Rajendran, V.
    Dagna, L.
    Buch, M. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 512 - 513
  • [4] Long-term exposure to telmisartan as monotherapy or combination therapy: Efficacy and safety
    Freytag, F
    Holwerda, NJ
    Karlberg, BE
    Meinicke, TW
    Schumacher, H
    BLOOD PRESSURE, 2002, 11 (03) : 173 - 181
  • [5] Safety and efficacy of filgotinib in Japanese patients with rheumatoid arthritis: Week 156 interim results in FINCH 4
    Tanaka, Yoshiya
    Matsubara, Tsukasa
    Atsumi, Tatsuya
    Amano, Koichi
    Ishiguro, Naoki
    Hirata, Shintaro
    Yamaoka, Kunihiro
    Combe, Bernard G.
    Nash, Peter
    Genovese, Mark
    Pechonkina, Alena
    Liu, Jie
    Kondo, Akira
    Fukada, Haruhiko
    De Leonardis, Francesco
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2024,
  • [6] Efficacy and Safety of Filgotinib in Patients with Inadequate Response to Methotrexate, with 4 or < 4 Poor Prognostic Factors: A Post Hoc Analysis of the FINCH 1 Study
    Combe, Bernard
    Tanaka, Yoshiya
    Buch, Maya
    Burmester, Gerd
    Bartok, Beatrix
    Pechonkina, Alena
    Han, Ling
    Emoto, Kahaku
    Kano, Shungo
    Hendrikx, Thijs
    Aletaha, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1816 - 1818
  • [7] EFFICACY AND SAFETY OF FILGOTINIB IN PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE, WITH 4 OR <4 POOR PROGNOSTIC FACTORS: A POST HOC ANALYSIS OF THE FINCH 1 STUDY
    Combe, B.
    Tanaka, Y.
    Buch, M. H.
    Burmester, G. R.
    Bartok, B.
    Pechonkina, A.
    Han, L.
    Emoto, K.
    Kano, S.
    Hendrikx, T.
    Aletaha, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 632 - 632
  • [8] EFFICACY OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH POOR PROGNOSTIC FACTORS: POST HOC ANALYSIS OF FINCH 3
    Aletaha, D.
    Westhovens, R.
    Gaujoux-Viala, C.
    Adami, G.
    Matsumoto, A.
    Bird, P.
    Messina, O.
    Buch, M. H.
    Bartok, B.
    Yin, Z.
    Guo, Y.
    Hendrikx, T.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 308 - 309
  • [9] Efficacy of Filgotinib in Patients with Rheumatoid Arthritis with Poor Prognostic Factors: Post Hoc Analysis of FINCH 3
    Westhovens, Rene
    Aletaha, Daniel
    Gaujoux-Viala, Cecile
    Adami, Giovanni
    Matsumoto, Alan
    Bird, Paul
    Messina, Osvaldo
    Buch, Maya
    Bartok, Beatrix
    Yin, Zhaoyu
    Guo, Ying
    Hendrikx, Thijs
    Burmester, Gerd
    SWISS MEDICAL WEEKLY, 2020, : 9S - 10S
  • [10] Long-term efficacy of rosiglitazone as monotherapy or in combination with metformin
    Jones, NP
    Mather, R
    Owen, S
    Porter, LE
    Patwardhan, R
    DIABETOLOGIA, 2000, 43 : A192 - A192
12345